Target intelligence / Profile preview

Gastric hydrochloric acid and gastrointestinal gas bubbles

Molecular classification
Inorganic compound, Physical/Chemical target, Other
01

Overview

Gastric hydrochloric acid is a primary component of gastric juice, secreted by parietal cells in the stomach to facilitate the breakdown of proteins and provide an innate immune barrier against ingested microorganisms (StatPearls, 2023). Gastrointestinal gas bubbles are formed from swallowed air or the fermentation of food by gut microbiota, often becoming trapped in the gastrointestinal tract and causing symptoms of bloating and pressure (NIH, 2022). In pathological states such as gastroesophageal reflux disease (GERD) or functional dyspepsia, the acidity of the stomach can cause mucosal damage or pain, while excessive gas leads to abdominal distension. Pharmacological management of these targets typically involves non-systemic agents: antacids like calcium carbonate or magnesium hydroxide chemically neutralize the acid, while simethicone acts as a surfactant to break down gas bubbles (PubChem, 2024). These treatments provide symptomatic relief by altering the chemical and physical environment of the gastrointestinal lumen rather than targeting specific cellular receptors. This dual target approach is common in over-the-counter formulations designed to address both acid-related distress and gas-related discomfort simultaneously (FDA, 2021).

Other names
Stomach acidGastric acidGI gasIntestinal gas bubblesGastric HCl
02

Mechanism of action

Antacids neutralize gastric hydrochloric acid through a chemical reaction, typically producing water and a salt, thereby increasing the gastric pH (StatPearls, 2023). Simethicone acts as an anti-foaming agent by decreasing the surface tension of gas bubbles in the stomach and intestines, allowing them to coalesce into larger bubbles that are more easily eliminated via belching or passing flatus (StatPearls, 2022).

03

Biological functions

DigestionImmune responseOther
04

Disease associations

Gastroesophageal reflux disease (GERD)Peptic ulcer diseaseDyspepsiaInfectionOther
05

Safety considerations

Electrolyte imbalanceMilk-alkali syndromeAltered drug absorptionAcid reboundMasking of serious underlying conditions
06

Interacting drugs

Aluminum hydroxide

4 more in the full profile.

07

Biomarkers

Gastric pHEsophageal pH monitoringBreath hydrogen test

Beyond the preview

Go deeper on Gastric hydrochloric acid and gastrointestinal gas bubbles.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastric hydrochloric acid and gastrointestinal gas bubbles.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call